Share Name Share Symbol Market Type Share ISIN Share Description
Tiziana Life Sciences LSE:TILS London Ordinary Share GB00BKWNZY55 ORD 3P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.50p -0.36% 137.00p 135.00p 139.00p - - - 0 16:35:20
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -7.3 -7.7 - 171.46

Tiziana Share Discussion Threads

Showing 376 to 396 of 400 messages
Chat Pages: 16  15  14  13  12  11  10  9  8  7  6  5  Older
DateSubjectAuthorDiscuss
16/1/2018
18:19
I don't drink so that's not a lot of good to me lol
osammyboy2
16/1/2018
12:01
Placing for 150 grand, should buy a round of drinks eh.
jpuff
12/1/2018
16:36
Thanks Stenick. Good to have some optimism.
asmodeus
12/1/2018
10:11
The FDA and EMA have already given Milciclib orphan drug designation, all is needed is proof of efficacy and tolerability and need,to get a marketing licence. I think they have proved that it has all three. From figures on Tils website about numbers of thymus cancers per year I have done a quick calculation of the potential size of market and it’s about £4.5 billion a year. They also have promising phase 1 results in other cancers. So in my opinion we should have some news shortly that is a game changer. Also a Chinese company is buying a major share in the Italian company that discovered Milciclib, Tils has the marketing rights, so China may well want Milciclib as well. As always DYOR. Good luck all.
stenick
18/12/2017
17:23
Right the spread is 4.9 to 5.
stenick
18/12/2017
15:00
5 Billion's over the top; not a penny over 4.9 in my opinion.
asmodeus
18/12/2017
09:37
Good news, they have money to progress trials. I reckon the next news will be that milciclib will pass the regulators and be put on sale, or a bid for the company will occur and be sold for £5 billion. All my own opinions, I know nothing.
stenick
13/12/2017
16:59
All news is bad news it would seem given the share price reaction. I'm just glad the cryptos are doing so well in the "real world" lol
jpuff
11/12/2017
22:14
Jpuff - you must be an early starter if 0700 is after hours!
supernumerary
08/12/2017
08:54
Excellent news, interested to hear that the existing drug for HCC is only 3% effective and for only 2/3months. Some have been taking Milciclib for upto 5years. A no brainer!
stenick
28/11/2017
12:31
Fast track FDA will only take 2months.
stenick
28/11/2017
08:49
£4 from broker again.
stenick
24/11/2017
13:32
Hopefully some income soon. Kunwar Shailubhai, CEO & CSO of Tiziana Life Sciences, commented: "Data from these two clinical studies demonstrating efficacy and long-term safety is a major milestone in clinical development of milciclib. We will work with regulatory agencies in US and Europe to develop plans to bring these first-in-class therapies to patients in need as soon as possible.”
stenick
23/11/2017
15:27
Agreed Jpuff. Tils has all the makings of a successful company. Can’t wait for news on liver cancer trial and foralumab trial.
stenick
23/11/2017
08:03
Well under the radar TILS and a good time to accumulate imho.
jpuff
23/11/2017
07:59
Brilliant, did not realise some people have been taking it for over 5yrs.
stenick
23/11/2017
07:16
Excellent news above.
jpuff
09/11/2017
14:27
????????????????????? %
rovi70
31/10/2017
16:03
🙉🙊🙈
stenick
31/10/2017
15:24
gosh!!!!!!
rovi70
04/10/2017
07:16
Somethings going on I bet. What it is, I don’t know . But something is going on. IMO.
stenick
Chat Pages: 16  15  14  13  12  11  10  9  8  7  6  5  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:30 V: D:20180119 17:36:43